abstract |
The invention relates to pharmaceutical formulations comprising an active pharmaceutical ingredient, a polyethylene glycol having a freezing point of at least about 30° C., and a crystallisation rate inhibitor. Solid dosage forms comprising said pharmaceutical formulations, processes for preparing these and their use in methods of treatment are also described. |